Resources

Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C

Showing 321 to 330 of 376 resources

  • Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
    This paper reports on the results of a 2011 EASL meeting and subsequent dialogue with patient groups and relevant experts in Europe. It summarises the current knowledge of HCV infection and the brain; prevalence, course, and neurobiology of IFN-a associated psychiatric side effects; possible risk factors for IFN-a associated depression and suicide attempts; psychiatric management of HCV infected patients before and during antiviral treatment; prevention of IFN- a associated psychiatric side effects; and psychiatric aspects of the new antivirals.
    UK, Rest of World 2012 Reports & Research PDF
  • Yorkshire and the Humber Quality Standards Framework for Hepatitis B and C: 2012
    In order to address the prevention and burden of hepatitis C (and B) effectively it is important that the four key elements of the pathway are in place as defined by the Department of Health. Whilst there have been many developments since 2004, this Quality Standards Framework still focuses on the four key elements of the hepatitis B and C pathway but provides more detail on how, in Yorkshire and the Humber, stakeholders can work effectively to deliver a quality pathway to patients regarding hepatitis B and C.
    Yorkshire and the Humber 2012 Other, Reports & Research PDF
  • Improving outcomes and supporting transparency. Part 1: A public health outcomes framework for England, 2013-2016
    The responsibility to improve and protect our health lies with us all – government, local communities and with ourselves as individuals.
    England Jan 2012 Reports & Research, Strategy & Planning PDF
  • The Silent Pandemic: Tackling Hepatitis C with Policy Innovation
    Hepatitis C may be the serious disease that most combines widespread prevalence with widespread ignorance. According to the World Health Organisation (WHO), this urgent public health problem kills 350,000 people per year, and 150 million have the chronic form of the hepatitis C virus (HCV). The incidence of new infections is simply not known at the global level. Yet, HCV is entirely preventable and largely curable.
    UK, Rest of World 2012 Reports & Research PDF
  • The Hepatitis C Trust Outreach & Testing Van
    This document summarises The Hepatitis C Trust’s Outreach and Testing Van service, which aims to increase diagnoses by reaching groups who may be at risk of hep C but who currently cannot, or do not, access testing through existing means. Given that most people in the UK today are undiagnosed, the testing van aims to overcome some of the key barriers to diagnosis.
    England 2011 Case study, Reports & Research PDF
  • The Sexual Health and Blood Borne Virus Framework 2011-15
    Sexual health and blood borne viruses continue to be of high priority for the Scottish Government. The Sexual
    Scotland Aug 2011 Reports & Research PDF
  • Wirral Drug and Alcohol Addiction Team (DAAT) Hep C Strategy
    The National Treatment Agency’s (NTA) aspirational target is for each DAAT partnership to ensure that 100% of their previous/current injecting drug user (IDU) population to have been tested for Hepatitis C. Many DAATs across the country have struggled to achieve this target and Wirral DAAT’s performance at the end of 2007/08 is at 20%.
    North West 2011 Case study, Strategy & Planning PDF
  • Pharmacy-based testing for hepatitis B and hepatitis C
    This report lays out The Hepatitis C Trust’s plan for a programme of pharmacy-based testing for hepatitis b and hepatitis c. It emphasises that community pharmacies are ideally placed to deliver basic public health information as well as, with the right training and support, screening for conditions such as viral hepatitis. The Hepatitis C Trust’s Pharmacy Testing Programme is designed to increase awareness and testing for hepatitis B and C through targeted, on-demand testing for people less likely to access mainstream services.
    UK 26 Jun 2011 Reports & Research PDF
  • Hepatitis C - Treatment and follow-up
    Valid until May 2014, this document provides a map of medicine for the treatment and follow-up of Hepatitis C.
    England 06 Jun 2011 Training, Tools & Templates PDF
  • Government response to the NHS Future Forum report
    Between April and June 2011, the NHS Future Forum, led by Professor Steve Field, heard the views of thousands of people – patients, professionals and members of the public. They listened to every professional group and toured every region in the country, producing a report for the Government on 13th June. The NHS Future Forum confirmed that there was considerable support for the principles of the Government’s reforms, but said that some of the ways in which it was putting those principles into practice could be improved.
    England Jun 2011 Reports & Research PDF

Pages